Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial
Moreno, Lucas ; Weston, Rebekah ; Owens, Cormac ; Valteau-Couanet, Dominique ; Gambart, Marion ; Castel, Victoria ; Zwaan, C Michel ; Nysom, Karsten ; Gerber, Nicolas ; Castellano, Aurora ; Laureys, Genevieve ; Ladenstein, Ruth ; Rössler, Jochen ; Makin, Guy ; Murphy, Dermot ; Morland, Bruce ; Vaidya, Sucheta ; Thebaud, Estelle ; van Eijkelenburg, Natasha ; Tweddle, Deborah A ; Barone, Giuseppe ; Tandonnet, Julie ; Corradini, Nadege ; Chastagner, Pascal ; Paillard, Catherine ; Bautista, Francisco J ; Gallego Melcon, Soledad ; De Wilde, Bram ; Marshall, Lynley ; Gray, Juliet ; Burchill, Susan A ; Schleiermacher, Gudrun ; Chesler, Louis ; Peet, Andrew ; Leach, Martin O ; McHugh, Kieran ; Hayes, Roisin ; Jerome, Neil ; Caron, Hubert ; Laidler, Jennifer ; Fenwick, Nicola ; Holt, Grace ; Moroz, Veronica ; Kearns, Pamela ; Gates, Simon ; Pearson, Andrew D J ; Wheatley, Keith
Journal of clinical oncology, 2024-04, Vol.42 (10), p.1135-1145 [Periódico revisado por pares]United States
Sem texto completo